PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti鈥揚D-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global PD-L1 and PIK3CA Testing Product market was valued at US$ 521.8 million in 2022 and is anticipated to reach US$ 1099.4 million by 2029, witnessing a CAGR of 11.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing Product.
The PD-L1 and PIK3CA Testing Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PD-L1 and PIK3CA Testing Product market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Agilent Technologies
Roche
QIAGEN
EntroGen
Foundation Medicine
Amoy Diagnostics
ACCB Biotech
Segment by Type
PD-L1
PIK3CA
Segment by Application
Hospital
Diagnostic Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PD-L1 and PIK3CA Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PD-L1 and PIK3CA Testing Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 PD-L1 and PIK3CA Testing Product Market Overview
1.1 Product Overview and Scope of PD-L1 and PIK3CA Testing Product
1.2 PD-L1 and PIK3CA Testing Product Segment by Type
1.2.1 Global PD-L1 and PIK3CA Testing Product Market Value Comparison by Type (2023-2029)
1.2.2 PD-L1
1.2.3 PIK3CA
1.3 PD-L1 and PIK3CA Testing Product Segment by Application
1.3.1 Global PD-L1 and PIK3CA Testing Product Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Global PD-L1 and PIK3CA Testing Product Market Size Estimates and Forecasts
1.4.1 Global PD-L1 and PIK3CA Testing Product Revenue 2018-2029
1.4.2 Global PD-L1 and PIK3CA Testing Product Sales 2018-2029
1.4.3 Global PD-L1 and PIK3CA Testing Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PD-L1 and PIK3CA Testing Product Market Competition by Manufacturers
2.1 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PD-L1 and PIK3CA Testing Product Average Price by Manufacturers (2018-2023)
2.4 Global PD-L1 and PIK3CA Testing Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PD-L1 and PIK3CA Testing Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PD-L1 and PIK3CA Testing Product, Product Type & Application
2.7 PD-L1 and PIK3CA Testing Product Market Competitive Situation and Trends
2.7.1 PD-L1 and PIK3CA Testing Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PD-L1 and PIK3CA Testing Product Players Market Share by Revenue
2.7.3 Global PD-L1 and PIK3CA Testing Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PD-L1 and PIK3CA Testing Product Retrospective Market Scenario by Region
3.1 Global PD-L1 and PIK3CA Testing Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PD-L1 and PIK3CA Testing Product Global PD-L1 and PIK3CA Testing Product Sales by Region: 2018-2029
3.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2018-2023
3.2.2 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2024-2029
3.3 Global PD-L1 and PIK3CA Testing Product Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2018-2029
3.3.1 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2018-2023
3.3.2 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2024-2029
3.4 North America PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
3.4.1 North America PD-L1 and PIK3CA Testing Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PD-L1 and PIK3CA Testing Product Sales by Country (2018-2029)
3.4.3 North America PD-L1 and PIK3CA Testing Product Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
3.5.1 Europe PD-L1 and PIK3CA Testing Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PD-L1 and PIK3CA Testing Product Sales by Country (2018-2029)
3.5.3 Europe PD-L1 and PIK3CA Testing Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
3.6.1 Asia Pacific PD-L1 and PIK3CA Testing Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PD-L1 and PIK3CA Testing Product Sales by Country (2018-2029)
3.6.3 Asia Pacific PD-L1 and PIK3CA Testing Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
3.7.1 Latin America PD-L1 and PIK3CA Testing Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PD-L1 and PIK3CA Testing Product Sales by Country (2018-2029)
3.7.3 Latin America PD-L1 and PIK3CA Testing Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
3.8.1 Middle East and Africa PD-L1 and PIK3CA Testing Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PD-L1 and PIK3CA Testing Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2018-2029)
4.1.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2018-2023)
4.1.2 Global PD-L1 and PIK3CA Testing Product Sales by Type (2024-2029)
4.1.3 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2018-2029)
4.2 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2018-2029)
4.2.1 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2018-2023)
4.2.2 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2024-2029)
4.2.3 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2018-2029)
4.3 Global PD-L1 and PIK3CA Testing Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2018-2029)
5.1.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2018-2023)
5.1.2 Global PD-L1 and PIK3CA Testing Product Sales by Application (2024-2029)
5.1.3 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2018-2029)
5.2 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2018-2029)
5.2.1 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2018-2023)
5.2.2 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2024-2029)
5.2.3 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2018-2029)
5.3 Global PD-L1 and PIK3CA Testing Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Agilent Technologies
6.1.1 Agilent Technologies Corporation Information
6.1.2 Agilent Technologies Description and Business Overview
6.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio
6.1.5 Agilent Technologies Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche PD-L1 and PIK3CA Testing Product Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 QIAGEN
6.3.1 QIAGEN Corporation Information
6.3.2 QIAGEN Description and Business Overview
6.3.3 QIAGEN PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio
6.3.5 QIAGEN Recent Developments/Updates
6.4 EntroGen
6.4.1 EntroGen Corporation Information
6.4.2 EntroGen Description and Business Overview
6.4.3 EntroGen PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio
6.4.5 EntroGen Recent Developments/Updates
6.5 Foundation Medicine
6.5.1 Foundation Medicine Corporation Information
6.5.2 Foundation Medicine Description and Business Overview
6.5.3 Foundation Medicine PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio
6.5.5 Foundation Medicine Recent Developments/Updates
6.6 Amoy Diagnostics
6.6.1 Amoy Diagnostics Corporation Information
6.6.2 Amoy Diagnostics Description and Business Overview
6.6.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio
6.6.5 Amoy Diagnostics Recent Developments/Updates
6.7 ACCB Biotech
6.6.1 ACCB Biotech Corporation Information
6.6.2 ACCB Biotech Description and Business Overview
6.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio
6.7.5 ACCB Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PD-L1 and PIK3CA Testing Product Industry Chain Analysis
7.2 PD-L1 and PIK3CA Testing Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PD-L1 and PIK3CA Testing Product Production Mode & Process
7.4 PD-L1 and PIK3CA Testing Product Sales and Marketing
7.4.1 PD-L1 and PIK3CA Testing Product Sales Channels
7.4.2 PD-L1 and PIK3CA Testing Product Distributors
7.5 PD-L1 and PIK3CA Testing Product Customers
8 PD-L1 and PIK3CA Testing Product Market Dynamics
8.1 PD-L1 and PIK3CA Testing Product Industry Trends
8.2 PD-L1 and PIK3CA Testing Product Market Drivers
8.3 PD-L1 and PIK3CA Testing Product Market Challenges
8.4 PD-L1 and PIK3CA Testing Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Agilent Technologies
Roche
QIAGEN
EntroGen
Foundation Medicine
Amoy Diagnostics
ACCB Biotech
听
听
*If Applicable.